• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global oncology molecular diagnostics market grew at a CAGR of around 12% during 2014-2019. Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing. Looking forward, IMARC Group expects the global oncology molecular diagnostics market to exhibit strong growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, cancer type, product, technology and end-user.

Breakup by Cancer Type:

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Others
     

Breakup by Product:

  • Instruments
  • Reagents
  • Others
     

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Chips and Microarrays
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • DNA and NGS Sequencing
  • Transcription Mediated Amplification (TMA)
  • Others
     

Breakup by End-User:

  • Hospitals and Clinics
  • Reference Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Abbott Laboratories, Bayer AG, BD (Becton, Dickinson and Company), Cepheid Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report:

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Oncology Molecular Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Cancer Type
    6.1    Breast Cancer
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Prostate Cancer
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Colorectal Cancer
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cervical Cancer
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Liver Cancer
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Lung Cancer
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Blood Cancer
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Others
        6.8.1 Market Trends
        6.8.2 Market Forecast
7    Market Breakup by Product
    7.1    Instruments
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Reagents
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Technology
    8.1    Polymerase Chain Reaction (PCR)
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    In Situ Hybridization
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Chips and Microarrays
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Mass Spectrometry
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    DNA and NGS Sequencing
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Transcription Mediated Amplification (TMA)
        8.7.1 Market Trends
        8.7.2 Market Forecast
    8.8    Others
        8.8.1 Market Trends
        8.8.2 Market Forecast
9    Market Breakup by End-User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Reference Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast 
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Agilent Technologies Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Abbott Laboratories
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    BD (Becton, Dickinson and Company)
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Cepheid Inc (Danaher Corporation)
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 SWOT Analysis
        15.3.7    Hologic, Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Qiagen N.V.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Siemens Healthcare
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sysmex Corporation
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014-2019
Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2019
Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2019
Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2019 
Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2019
Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2019
Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2020-2005
Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification- TMA) Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification- TMA) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025 
Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025 
Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million US$), 2020-2025
Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2020-2025
Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2020-2025 
Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Oncology Molecular Diagnostics Market Structure
Table 8: Global: Oncology Molecular Diagnostics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links